Industry News
Industry leaders to take part in annual industry position survey
AusBiotech is pleased to once again conduct the annual CEO Industry Position Survey 2012, this year proudly supported by Grant Thornton. [ + ]
Grant Watch
Our regular roundup of news and announcements in the wild world of scientific and health & medical research grants and funding. [ + ]
Technique enables in-depth study of two-dimensional electronic states within crystals
A new spectroscopy technique enables the investigation of two-dimensional electron states both at the surface and within crystals. [ + ]
Research identifies mutations underlying human hereditary hearing loss
Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche’s NimbleGen Custom Sequence Capture 385K array, to identify the gene mutated in the disease locus of the X-chromosome of a Spanish family with hereditary hearing loss. [ + ]
Bootylicious fly named after Beyonce
A new species of horse fly with a notably resplendent abdomen has been named after the American pop diva, Beyonce. [ + ]
Seismometers reveal Australia’s geological history
Researchers from The Australian National University have used the latest earthquake-measuring technology to image the tectonic plate beneath south-east Australia and reveal for the first time the continent’s geological building blocks. [ + ]
A new year, a new look and good news is rolling in already…
2011 ended on a high for the Australian biotechnology industry, and 2012 is already off to a strong start for the sector. [ + ]
Australian native plants found to have anti-microbial properties
A Queensland collaborative research programme has found common native Australian plums can extend the shelf life of meat products. [ + ]
Starpharma to advance with phase III studies for VivaGel
Phase III trials of VivaGel to commence shortly after receiving FDA agreement on study design in anticipation of application for regulatory approval. [ + ]
Bionomics scores deal worth up to US$345 million
Deal with US pharmaceutical company Ironwood to develop anti-anxiety compound BNC210 could be worth up to US$345 million for the Adelaide-based biotech. [ + ]
Web resource for biobanking
CryoFeed is a web-based information resource for researchers who cryopreserve biological specimens. The microsite, developed by Wheaton, is a place where scientists can find the latest biobank related news and technical tips for topics like sample containment, management (tracking, batching and storing) and processing. Visitors can sign up for free updates, post comments and suggest topics for articles. [ + ]
Feature: Catching the sequencing bug
Dr Tony Papenfuss has shifted his energies from astrophysics to bioinformatics, and is about to tackle the itchy problem of sequencing the scabies genome. [ + ]
Feature: Epigenetic mischief makers
Dr Fatima Valdés-Mora has added yet another epigenetic mechanism to the growing list that allow cancers to run amok. [ + ]
Feature: Fever pitch
Professor Suresh Mahalingam and his team have made some intriguing discoveries that could lead to treatments of some nasty mosquito-borne diseases. [ + ]
QRxPharma to form US sales partnership
Drug development company QRxPharma (ASX:QRX) has agreed to form a partnership with Actavis covering commercialisation of its lead product, MoxDuo, in the US market. [ + ]
